Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Maravai LifeSciences Holdings, Inc. (MRVI)

29.4   0.99 (3.48%) 07-02 16:21
Open: 28.27 Pre. Close: 28.41
High: 29.42 Low: 27.63
Volume: 892,204 Market Cap: 7,503(M)
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 29.47 - 29.61 29.61 - 29.74
Low: 27.29 - 27.45 27.45 - 27.6
Close: 29.13 - 29.4 29.4 - 29.65

Technical analysis

as of: 2022-07-01 4:23:46 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 36.45     One year: 41.13
Support: Support1: 24.72    Support2: 20.57
Resistance: Resistance1: 31.21    Resistance2: 35.22
Pivot: 27.34
Moving Average: MA(5): 28.31     MA(20): 28.09
MA(100): 33.2     MA(250): 38.59
MACD: MACD(12,26): -0.9     Signal(9): -1.2
Stochastic oscillator: %K(14,3): 79.3     %D(3): 61.4
RSI: RSI(14): 51.7
52-week: High: 63.54  Low: 23.15
Average Vol(K): 3-Month: 1,416 (K)  10-Days: 1,239 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ MRVI ] has closed Bollinger Bands are 47.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 01 Jul 2022
Maravai LifeSciences Announces May and June 2022 Investor Conference Schedule -

Thu, 30 Jun 2022
We Did The Math IYH Can Go To $323 - Nasdaq

Mon, 27 Jun 2022
Maravai LifeSciences adds Peter Leddy as chief administrative officer(NASDAQ:MRVI) - Seeking Alpha

Tue, 21 Jun 2022
Analyzing Revance Therapeutics (NASDAQ:RVNC) and Maravai LifeSciences (NASDAQ:MRVI) - Defense World

Thu, 16 Jun 2022
Stock Traders Buy High Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI) - Defense World

Wed, 08 Jun 2022
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Expected to Announce Earnings of $0.46 Per Share - Defense World

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 131 (M)
Shares Float 89 (M)
% Held by Insiders 0.1 (%)
% Held by Institutions 99.9 (%)
Shares Short 4,740 (K)
Shares Short P.Month 5,320 (K)

Stock Financials

EPS 4.71
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.29
Profit Margin (%) 22.7
Operating Margin (%) 68.2
Return on Assets (ttm) 21.3
Return on Equity (ttm) 134
Qtrly Rev. Growth 132.3
Gross Profit (p.s.) 5.01
Sales Per Share 6.07
EBITDA (p.s.) 4.34
Qtrly Earnings Growth 226.6
Operating Cash Flow 369 (M)
Levered Free Cash Flow 212 (M)

Stock Valuations

PE Ratio 6.24
PEG Ratio -12.7
Price to Book value 12.78
Price to Sales 4.83
Price to Cash Flow 10.48

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.